As Artificial Intelligence (AI) sweeps across industries, the healthcare sector finds itself at the forefront of this revolutionary wave. AI is driving personalized treatments, boosting operational efficiency, and bringing high-quality care to communities across the world. 

At Idoven, we’re honored to be a part of the AI revolution in healthcare, and build technology to detect cardiovascular disease earlier so patients can live healthier lives. As part of our commitment to the UN Sustainable Development Goals to improve global health and wellbeing, our CEO, Manuel Marina Breysse, will be speaking at the AI For Good Summit 2023 in Geneva this week to share more about the transformative global impact of AI in cardiovascular care. 

The Technological Promise of AI 

Diego Piacentini - former SVP at Amazon, GM Europe of Apple, Italy’s Government Commissioner for Digital Transformation and Idoven advisor - is strongly convinced of the transformative power of AI in healthcare: “AI technology like Idoven is the key to unlocking solutions to humanity’s pressing health issues that have yet to be solved. It will empower physicians and health systems to provide objective, accurate, and reliable data to support patient care.” We could not agree more. 

For Idoven, our AI-based technology significantly improves the speed, accuracy, and interpretation of electrocardiograms (ECGs) to detect cardiac patterns that could indicate a cardiac disease. The ECG is the leading complementary test to diagnose heart problems - with over 300 million ECGs performed annually across the world - however in many countries providing an accurate ECG analysis can be difficult due to a scarcity of qualified physicians. By leveraging AI, we’re able to bring cardiologist-level accuracy to this important diagnostic tool. 

AI technology like Idoven is the key to unlocking solutions to humanity’s pressing health issues that have yet to be solved. It will empower physicians and health systems to provide objective, accurate, and reliable data to support patient care.

- Diego Piacentini - former SVP at Amazon, GM Europe of Apple, Italy’s Government Commissioner for Digital Transformation and Idoven advisor

Bringing AI Technology to a Global Scale 

At the core of Idoven's mission lies the belief that geographical location should not be a barrier to quality healthcare. Manuel Marina Breysse, Cardiologist, Co-founder, and CEO of Idoven, shares what drove him and his co-founder, Jose Maria Lillo Castellano, to start the company: "We truly believe that where you live should not determine your healthcare access. By digitizing the diagnostic process through our platform, we can detect and diagnose cardiac problems anywhere, anytime."

Idoven's journey started in 2018 with a bold goal: to diagnose patients in a new city every 30 days. Fast forward to 2023 and this ambitious vision has become a reality. We are thrilled to share that our AI-powered platform is supporting patients in over 30 countries across all seven continents. We are rapidly growing to reach more patients and geographies so we can bring high-quality diagnostic cardiovascular care to those that need it most. 

We truly believe that where you live should not determine your healthcare access. By digitizing the diagnostic process through our platform, we can detect and diagnose cardiac problems anywhere, anytime.

-Manuel Marina, Cardiologist, Co-founder, and CEO of Idoven

The Crucial Role of Regulation and Privacy 

As we’ve seen, AI-powered technologies can foster scientific breakthroughs at an unprecedented speed and scale. In order to build these technologies, very large and diverse data sets are required to train, validate and provide evidence of the effectiveness of the AI. It is incredibly important that these datasets are handled securely and ethically, respecting privacy concerns and regulatory standards that are unique to different countries and regions around the world. 

Cristina Bescos, Director of Innovation at EIT Health and CEO of EIT Health Spain, describes the importance of balancing technological potential and regulatory adherence: "Cardiovascular diseases account for 32% of all deaths worldwide and therefore require cutting-edge technological solutions that can be implemented equally at a global level. Idoven's platform represents the kind of technological solution that is easily adaptable to the different complex regulatory requirements and healthcare systems, which have common needs and challenges on their agendas."

Idoven's platform represents the kind of technological solution that is easily adaptable to the different complex regulatory requirements and healthcare systems.

-Cristina Brescos, Director of Innovation at EIT Health and CEO of EIT Health Spain

Looking Ahead: The Future of AI in Healthcare

The innovative use of AI by Idoven is a powerful testament to how AI can be harnessed to accelerate progress towards the UN's 2030 Sustainable Development Goals, leveraging vast datasets securely and ethically. Frederic Werner, Head of Strategic Engagement at the United Nations International Telecommunication Union (ITU), affirms this potential: “The development of companies like Idoven is very important. AI-powered technology can act as a catalyst to ensure the UN's 2030 Sustainable Development Goals."

The development of companies like Idoven is very important. AI-powered technology can act as a catalyst to ensure the UN's 2030 Sustainable Development Goals.

- Frederic Werner, Head of Strategic Engagement at the United Nations

In a world where AI holds the promise to surmount distance and time barriers, Idoven is at the forefront of this transformation. We are committed to continuous innovation, assuring that our technology delivers the highest quality cardiac care, no matter where the patient is. 

‍